The dopamine D3 receptor antagonist, (+)-S14297, blocks the cataleptic properties of haloperidol in rats
- 5 March 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 321 (3) , R7-R9
- https://doi.org/10.1016/s0014-2999(97)00049-6
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Inverse Agonism at Dopamine D2 Receptors Haloperidol-Induced Prolactin Release from GH4C1 Cells Transfected with the Human D2 Receptor Is Antagonized by R(−)-n-propylnorapomorphine, Raclopride, and PhenoxybenzamineNeuropsychopharmacology, 1996
- A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.Proceedings of the National Academy of Sciences, 1996
- Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptorsNature, 1995
- The dopamine D3 receptor and schizophrenia: pharmacological, anatomical and genetic approachesEuropean Neuropsychopharmacology, 1995
- Understanding the Mechanism of Action of Atypical Antipsychotic DrugsThe British Journal of Psychiatry, 1993
- The dopamine D3-receptor: A postsynaptic receptor inhibitory on rat locomotor activityJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1993